Evaluation of Virtual Reality Headsets on Cancer Patients During Day Hospital Stay

N/ACompletedNCT06814912

Institut Sainte Catherine100 enrolled

Overview

Use of virtula reality headsets during treatment course on day hospitalized cancer patients

Study Type

INTERVENTIONAL

Allocation

Purpose

PREVENTION

Masking

NONE

Enrollment

100

Conditions

Cancer

Interventions

Survey using a questionnaireOTHER

virtual reality headset is added during treatment administration. Patient must complete a survey at the end of treatment administration and virtual headset use.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * cancer patients * chemotherapy treatment Exclusion Criteria: \-

Locations (1)

ICAP

Avignon, France

Outcomes

Primary Outcomes

Rate of patients with nausea reduction compared with preview treatment administration

survey : improvement of nausea

Time frame: From the first chemotherapy injection until the end of chemotherapy injection with the virtual reality headset (at the end of the third cycle; each cycle is 21 days) )

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.